Hair News

FDA Says It's Time to Ease Restrictions on Testosterone Replacement Therapy

Rubenhair Latvia
2 min read
01.01.2026
FDA Says It's Time to Ease Restrictions on Testosterone Replacement Therapy

**New Developments in Testosterone Replacement Therapy (TRT)** An expert panel from the Food and Drug Administration (FDA) has recommended easing restrictions on testosterone replacement therapy (TRT).

**New Developments in Testosterone Replacement Therapy (TRT)**

An expert panel from the Food and Drug Administration (FDA) has recommended easing restrictions on testosterone replacement therapy (TRT). This move could make TRT more accessible to millions of men, but also raises questions about oversight and prescribing practices.

The FDA panel's recommendations follow new clinical trials that suggest TRT does not increase the risk of heart attack, stroke, or prostate cancer in appropriately selected males. The panel expressed strong support for TRT, arguing that it could benefit a broader group of individuals than those currently covered by its approved indications.

Current Uses and Limitations of TRT

TRT is currently only approved for low testosterone (hypogonadism) associated with specific medical causes, such as:

  • testicular dysfunction
  • pituitary disorders
  • hypothalamic disease

However, the FDA's indications are misaligned with guidance from professional groups like the American Urological Association, which recommends considering testosterone therapy in males with confirmed low testosterone levels and clinical symptoms.

New Recommendations for TRT Regulation

The expert panel recommended sweeping regulatory changes for TRT, including:

  • expanding FDA-approved indications to include age-related low testosterone
  • removing its Schedule III controlled substance designation

The panel also emphasized the importance of routine screening for low testosterone, similar to lipid panels and other commonly ordered blood tests.

Implications and Next Steps

If adopted, these changes could have a significant impact on men's health. As Dr. Helen L. Bernie, a urologist at Indiana University and member of the expert panel, noted: "We are failing men. If we want to improve the health of American men, if we want to close the mortality gap, we must recognize testosterone deficiency for what it is: a public health issue."

Learn more about hair transplant at Rubenhair clinic.

Get a Free Consultation

Consult with our specialists about FUE procedure, PRP therapy or hair transplant.

Do you have questions?

Contact us and get a free consultation about hair transplantation

+371 267 777 76